From Casetext: Smarter Legal Research

Bayer Healthcare Pharm. Inc. v. Curtis Ulleseit

Supreme Court of the United States.
Oct 4, 2021
142 S. Ct. 57 (2021)

Opinion

No. 20-1144.

10-04-2021

BAYER HEALTHCARE PHARMACEUTICALS INC., et al., Petitioners, v. CURTIS ULLESEIT, et al.


On petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit. Petition for writ of certiorari granted. Judgment vacated, and case remanded to the United States Court of Appeals for the Ninth Circuit for further consideration in light of BP p.l.c. v. Mayor and City Council of Baltimore , 593 U.S. ––––, 141 S.Ct. 1532, 209 L.Ed.2d 631 (2021).


Summaries of

Bayer Healthcare Pharm. Inc. v. Curtis Ulleseit

Supreme Court of the United States.
Oct 4, 2021
142 S. Ct. 57 (2021)
Case details for

Bayer Healthcare Pharm. Inc. v. Curtis Ulleseit

Case Details

Full title:BAYER HEALTHCARE PHARMACEUTICALS INC., et al., Petitioners, v. CURTIS…

Court:Supreme Court of the United States.

Date published: Oct 4, 2021

Citations

142 S. Ct. 57 (2021)
211 L. Ed. 2d 1